ACLS

Axcelis Technologies, Inc.

58
Fundamentals41/ 100
Valuation33/ 100
Upside potential77/ 100
Risk potential21/ 100

ACLS has lower modeled downside risk, despite its lower overall score.

INTC

Intel Corporation

65
Fundamentals73/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential42/ 100

INTC has the edge over ACLS overall, supported by stronger fundamentals and stronger valuation.

ACLS Fundamentals

MetricStatus
Healthy
Stable
Stable
Strong

ACLS's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.

INTC Fundamentals

MetricStatus
Healthy
Under pressure
Healthy
Healthy

INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.

ACLS PE Valuation

CHEAPFAIREXPENSIVE15x30x45x61x
CHEAPFAIREXPENSIVE15x30x45x61x
LevelPEPriceVs current
Cheap14x$48.20-55%
Forward18x$108—
Fair22x$73.95-32%
Current32x$108—
Expensive34x$113+4.9%

Historical ranges are pointers, not guarantees.

ACLS's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.

INTC PE Valuation

INTC has no meaningful PE right now: it lost money over the past year.

ACLS Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for ACLS, with profitability improving.

INTC Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Broad
Low

Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.

ACLS Risk to reward

ScenarioChangePrice
Upside+70%$184.04
Downside-21%$85.25

Calculated from the latest close: $108.06 on Nov 12.

ACLS has a better modeled risk to reward balance than INTC, with more potential upside relative to its potential downside.

INTC Risk to reward

ScenarioChangePrice
Upside+76%$107.41
Downside-42%$35.74

Calculated from the latest close: $61.20 on Nov 12.

INTC trails ACLS on modeled risk to reward, with less potential upside relative to its potential downside.

ACLS Earnings Per Share

Q4 2023: $7.43Q1 2024: $7.57Q2 2024: $7.26Q3 2024: $6.76Q4 2024: $6.15Q1 2025: $5.46Q2 2025: $4.89Q3 2025: $4.23Q4 2025: $3.80Q1 2026: $3.22Q2 2026: $2.99Q3 2026: $3.37Forward: $6.05
Q4 2023: $7.43Q1 2024: $7.57Q2 2024: $7.26Q3 2024: $6.76Q4 2024: $6.15Q1 2025: $5.46Q2 2025: $4.89Q3 2025: $4.23Q4 2025: $3.80Q1 2026: $3.22Q2 2026: $2.99Q3 2026: $3.37Forward: $6.05
QuarterTTM EPSYoY
Forward$6.05+80%
Q3 2026$3.37-20%
Q2 2026$2.99-39%
Q1 2026$3.22-41%
Q4 2025$3.80-38%
Q3 2025$4.23-37%
Q2 2025$4.89-33%
Q1 2025$5.46-28%
Q4 2024$6.15-17%

ACLS has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.

INTC Earnings Per Share

Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
QuarterTTM EPSYoY
Forward$1.41—
Q3 2026-$2.39-24000%
Q2 2026-$2.09+$2.68
Q1 2026-$0.60+$3.88
Q4 2025-$0.06+$4.32
Q3 2025$0.01+$3.72
Q2 2025-$4.77-2088%
Q1 2025-$4.48-562%
Q4 2024-$4.38-1195%

INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.

ACLS Quarterly Revenue

Q4 2023: $310MQ1 2024: $252MQ2 2024: $257MQ3 2024: $257MQ4 2024: $252MQ1 2025: $193MQ2 2025: $195MQ3 2025: $214MQ4 2025: $238MQ1 2026: $199MQ2 2026: $215MQ3 2026: $238M
Q4 2023: $310MQ1 2024: $252MQ2 2024: $257MQ3 2024: $257MQ4 2024: $252MQ1 2025: $193MQ2 2025: $195MQ3 2025: $214MQ4 2025: $238MQ1 2026: $199MQ2 2026: $215MQ3 2026: $238M
QuarterRevenueYoY
Q3 2026$237.8M+11%
Q2 2026$215.2M+11%
Q1 2026$199M+3.3%
Q4 2025$238.3M-5.6%
Q3 2025$213.6M-17%
Q2 2025$194.5M-24%
Q1 2025$192.6M-24%
Q4 2024$252.4M-19%

ACLS's revenue is recovering but still below its 2023 peak: $238M last quarter, up 11% from the same quarter a year ago.

INTC Quarterly Revenue

Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
QuarterRevenueYoY
Q3 2026$16.5B+21%
Q2 2026$16.1B+25%
Q1 2026$13.6B+7.2%
Q4 2025$13.7B-4.1%
Q3 2025$13.7B+2.8%
Q2 2025$12.9B+0.2%
Q1 2025$12.7B-0.4%
Q4 2024$14.3B-7.4%

INTC has the edge over ACLS on sales, with more consistent year-over-year improvement.

ACLS Free Cash Flow

Q4 2023: $55MQ1 2024: $41MQ2 2024: $38MQ3 2024: $42MQ4 2024: $8MQ1 2025: $35MQ2 2025: $38MQ3 2025: $43MQ4 2025: −$9MQ1 2026: $16MQ2 2026: $15MQ3 2026: $38M
Q4 2023: $55MQ1 2024: $41MQ2 2024: $38MQ3 2024: $42MQ4 2024: $8MQ1 2025: $35MQ2 2025: $38MQ3 2025: $43MQ4 2025: −$9MQ1 2026: $16MQ2 2026: $15MQ3 2026: $38M
QuarterFree cash flowYoY
Q3 2026$37.7M-13%
Q2 2026$14.8M-61%
Q1 2026$16.3M-53%
Q4 2025-$8.9M-210%
Q3 2025$43.3M+3.6%
Q2 2025$37.7M-0.8%
Q1 2025$34.8M-14%
Q4 2024$8.1M-85%

ACLS still generates free cash flow, though less than at its 2022 peak: $60M over the past year.

INTC Free Cash Flow

Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
QuarterFree cash flowYoY
Q3 2026$1.1B+774%
Q2 2026$4.5B+$6B
Q1 2026-$2.5B+$1.8B
Q4 2025$800M+$3.5B
Q3 2025$121M+$2.5B
Q2 2025-$1.5B+$1.9B
Q1 2025-$4.4B+$2.8B
Q4 2024-$2.7B-$597M

INTC has the edge over ACLS on cash flow, with more consistent year-over-year improvement.

ACLS Total Shares

Q4 2023: 33MQ1 2024: 33MQ2 2024: 33MQ3 2024: 33MQ4 2024: 33MQ1 2025: 32MQ2 2025: 32MQ3 2025: 31MQ4 2025: 32MQ1 2026: 31MQ2 2026: 31MQ3 2026: 31M
Q4 2023: 33MQ1 2024: 33MQ2 2024: 33MQ3 2024: 33MQ4 2024: 33MQ1 2025: 32MQ2 2025: 32MQ3 2025: 31MQ4 2025: 32MQ1 2026: 31MQ2 2026: 31MQ3 2026: 31M
PeriodChange %Net change
Quarterly-0.1%-29K shares
1 year-1.1%-345K shares
3 years-6.2%-2.1M shares
5 years-8.8%-3M shares
Available history-8%-2.7M shares

ACLS has the edge over INTC on shareholder dilution, with a more favorable share count trend.

INTC Total Shares

Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
PeriodChange %Net change
Quarterly+4%+203M shares
1 year+17%+776M shares
3 years+25%+1.1B shares
5 years+30%+1.2B shares
Available history+19%+834M shares

INTC has 5.3B diluted shares, up 17% from a year ago.

ACLS Net Leverage

Q4 2023: -0.6xQ1 2024: -0.5xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -1.0xQ3 2025: -1.2xQ4 2025: -1.1xQ1 2026: -1.3xQ2 2026: -1.5xQ3 2026: -1.7x
Q4 2023: -0.6xQ1 2024: -0.5xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -1.0xQ3 2025: -1.2xQ4 2025: -1.1xQ1 2026: -1.3xQ2 2026: -1.5xQ3 2026: -1.7x
QuarterNet LeverageStatus
Q3 2026-1.7xNet Cash
Q2 2026-1.5xNet Cash
Q1 2026-1.3xNet Cash
Q4 2025-1.1xNet Cash
Q3 2025-1.2xNet Cash
Q2 2025-1.0xNet Cash
Q1 2025-0.9xNet Cash
Q4 2024-0.6xNet Cash

ACLS has the edge over INTC on leverage, with a lower net debt burden relative to earnings.

INTC Net Leverage

Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
QuarterNet LeverageStatus
Q3 20262.0xHealthy
Q2 20263.1xElevated
Q1 20263.9xElevated
Q4 20253.4xElevated
Q3 20254.0xElevated
Q1 202569.6xHigh
Q3 202423.8xHigh
Q2 20244.3xHigh

INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.

ACLS Weekly Momentum

MetricValueStatus
RSI44.5Neutral
Stochastic23.9Neutral

ACLS's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).

INTC Weekly Momentum

MetricValueStatus
RSI38.1Neutral
Stochastic7.7Oversold

INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).

ACLS PE vs Technology Sector

MetricACLSSector medianRelative
PE32x28x15% above
PE %823547 pts above

ACLS is trading at 32x earnings, a 15% premium to the Technology sector's median of 28x.

INTC PE vs Technology Sector

MetricINTCSector medianRelative
PEN/A28x—

INTC has no meaningful PE right now: it lost money over the past year.

ACLS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$116.06.8% below
20 week MA$123.913% below
50 week MA$117.78.2% below
100 week MA$93.615% above
200 week MA$110.62.3% below

ACLS's trend is mixed: it's above one of its five weekly moving averages, and 2.3% below its 200-week average.

INTC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$88.431% below
20 week MA$95.336% below
50 week MA$79.323% below
100 week MA$52.118% above
200 week MA$42.544% above

INTC has the edge over ACLS on trend strength, trading above more of its moving averages.

ACLS Yearly ROI

YearStart priceEnd priceROI
2020$24.2$29.2+21%
2021$29.2$68.1+133%
2022$68.1$80.3+18%
2023$80.3$129.7+62%
2024$129.7$71.2-45%
2025$71.2$82.6+16%
2026 YTD$82.6$108.1+31%

ACLS's yearly returns have swung widely, from +133% in 2021 to −45% in 2024. It's up 31% so far in 2026.

INTC Yearly ROI

YearStart priceEnd priceROI
2020$60.1$47.1-22%
2021$47.1$51.3+9%
2022$51.3$26.1-49%
2023$26.1$50.3+93%
2024$50.3$20.3-60%
2025$20.3$36.2+78%
2026 YTD$36.2$61.2+69%

INTC has the edge over ACLS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key